Lopez RD, Waller EK, Lu P-H, Negrin RS. CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion and function of CD56+ T Cells: Cancer Immunology and Immunotherapy 49:629-640, 2001.
Guo B, Hollmig KH and Lopez RD. Down-regulation of IL-2 receptor a (CD25) characterizes human γδ-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12. Cancer Immunology and Immunotherapy. 50:625-637, 2002.
Liu Z, Guo BL, Gehrs BC, Nan L and Lopez RD. Ex vivo expanded human Vg9Vd2+ γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. Journal of Urology. 173:1552-1556, 2005.
Lopez RD. Exploiting the Innate Antitumor Properties of γδ-T Cells for the Immunotherapy of Human Cancer. The Hematologist (American Society of Hematology News and Reports, Invited Mini Review). July/August 2007.
Liu Z, Eltoum I-E, Guo BL, Beck B and Lopez RD. Protective immunosurveillance and therapeutic antitumor activity of γδ-T cells demonstrated in a mouse model of prostate cancer. Journal of Immunology 180:6044-6053, 2008.
Liu Z, Guo BL and Lopez RD. Expression of ICAM-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human γδ-T cells: Implications in the design of γδ-T cell-based immunotherapies for pancreatic cancer. Journal of Gastroenterology and Hepatology (in press).